Pasar al contenido principal

POLIMEROS TERAPEUTICOS DISEÑADOS PARA CRUZAR LA BARRERA HEMATOENCEFALICA PARA EL TRATAMIENTO DE DESORDENES NEURODEGENERATIVOS- EXPLORANDO LA RUTA INTRANASAL.

SAF2016-80427-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Nebot, V. J.
  • Dordevic, S.
  • Requejo-Aguilar, R.
  • Alastrue-Agudo, A.
  • Zagorodko, O.
  • Armiñán, A.
  • Martinez-Rojas, B.
  • Vicent, M.J.
  • Moreno Manzano, V.
[EN] Rho/ROCK signaling induced after spinal cord injury (SCI) contributes to secondary damage by promoting apoptosis, inflammation, and axon growth inhibition. The specific Rho-kinase inhibitor fasudil can contribute to functional regeneration after SCI, although inherent low stability has hampered its use. To improve the therapeutic potential of fasudil, we now describe a family of rationally-designed bioresponsive polymer-fasudil conjugates based on an understanding of the conditions after SCI, such as low pH, enhanced expression of specific proteases, and a reductive environment. Fasudil conjugated to poly-l-glutamate via a self-immolative redox-sensitive linker (PGA-SS-F) displays optimal release kinetics and, consequently, treatment with PGA-SS-F significantly induces neurite elongation and axon growth in dorsal root ganglia explants, spinal cord organotypic cultures, and neural precursor cells (NPCs). The intrathecal administration of PGA-SS-F after SCI in a rat model prevents early apoptosis and induces the expression of axonal growth- and neuroplasticity-associated markers to a higher extent than the free form of fasudil. Moreover, a combination treatment comprising the acute transplantation of NPCs pre-treated with PGA-SS-F leads to enhanced cell engraftment and reduced cyst formation after SCI. In chronic SCI, combinatory treatment increases the preservation of neuronal fibers. Overall, this synergistic combinatorial strategy may represent a potentially efficient clinical approach to SCI treatment., This research was funded by FEDER/Ministerio de Ciencia e Innovacion -Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF], Ministerio de Ciencia e Innovacion [SAF2016-80427-R, PID2019-108806RB-I00], Fundacio Marato TV3 [20172230, 20172231 and 20172110] Fundacion Step by Step, Agencia Valenciana de Innovacion (AVI) [INNVAL10/19/047] and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery

  • Conejos-Sánchez, Inmaculada
  • Sebastián, Víctor
  • Vicent, María J.
I. Conejos-Sánchez et al., Data will be made available on request., Intranasal administration represents a safe and non-invasive route for drug delivery to the brain; however, clinical translation remains limited due to anatomical and physiological barriers. We present a modular hybrid biomaterial platform (NanoInBrain) that bypasses the blood-brain barrier via the olfactory route and enables central nervous system (CNS) drug delivery. The platform integrates a rationally designed polypeptide-based nanocarrier with a depot-forming hydrogel vehicle - a hyaluronic acid-poly-L-glutamate crosspolymer (HA-CP, Yalic®) - adapted from dermatological applications to enhance nasal mucosal retention and brain uptake. We engineered the nanocarrier system using star-shaped poly-L-glutamate (StPGA) architectures and systematically tuned physicochemical properties to optimize mucosal interaction and CNS diffusion. We introduced mucoadhesive and mucodiffusive functionalities via C-terminal odorranalectin (OL) conjugation, which improved nasal epithelium permeation through receptor-mediated mechanisms. Redox-responsive disulfide crosslinking (StPGA-CL-SS) further enhanced mucosal transport by enabling thiol-mediated anchoring to mucin glycoproteins, outperforming inert click-crosslinked variants. Ex vivo Franz diffusion studies and a nasal-mucosa-on-chip model demonstrated robust permeation, with in vivo imaging confirming brain distribution and intracellular uptake in neurons and microglia. Incorporation of HA-CP prolonged nasal residence (∼4 h) and increased total brain accumulation while being well-tolerated. This new platform combines architectural tunability, bioresponsive surface chemistry, and depot-mediated delivery in a scalable, biocompatible nose-to-brain delivery system with potential for treating neurological disorders., This work was supported by the European Research Council (grant ERC-CoG-2014-648831 ″MyNano” and ERC-PoC- 2022-POC1 ″POLYBRAINT”) to M.J.V.); Health Foundation La Caixa Research Project NanoGBA (HR22-00602) and Caixa Impulse NanoERT (CI24-20222); the Spanish Ministry of Science, Innovation, and Universities (SAF2016-80427-R, PID2019-108806RB-I00 to M.J.V.; RTC-2017-6465-1, C.F-L Grant PTQ2018-010251 and D.M − B, Grant Industrial PhD DI-14-06926); the MINECO/FEDER, UE; European Regional Development Fund (ERDF) included in the ERDF operational program of Comunidad Valenciana 2014-2020; the Valencian Council for Education, Culture, University and Employment (CIPROM/2023/053) to J.M.G-V and V.H-P; the Valencian Innovation Agency (AVI) (L.T-C INNTAL31/19/005) and the Generalitat Valenciana (I.D-P, Grant VALi+d ACIF-2016-021 and BEFPI/2018/055). I.C-S. is funded by AEEC Junior Grant (Ref INVES211323CONE), and L.I.T.-S. has a predoctoral contract by the Valencian Council for Education, Universities and Employment (ACIF2021/420). VS acknowledges funding from project PID2024-160339OB-I00, PID2021-127847OB-I00, ‘Severo Ochoa’ Programme for Centres of Excellence in R&D of the Spanish Ministry of Science, Innovation and Universities (MICIU CEX2023-001286-S MICIU/AEI /10.13039/501100011033)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed